Kieran George Mooney

Title: Kieran George Mooney: Innovator in Pharmaceutical Treatments

Introduction

Kieran George Mooney is a notable inventor based in Lyme, Connecticut, who has made significant contributions to the field of pharmaceuticals. His work primarily focuses on innovative methods for treating non-alcoholic steatohepatitis (NASH), a condition that affects liver health.

Latest Patents

Mooney holds a patent for "Methods of treating a patient afflicted with non-alcoholic steatohepatitis (NASH)." This patent describes pharmaceutical carriers that provide an environment of physical and chemical stability. The formulation includes a therapeutically effective amount of an active pharmaceutical ingredient (API) compound, antioxidants, chelators, and a vehicle base comprising water and non-aqueous solvents. Additionally, it incorporates absorption enhancers, gelling agents, and pH buffering agents to optimize treatment efficacy.

Career Highlights

Throughout his career, Kieran Mooney has demonstrated a commitment to advancing medical treatments through innovative research and development. His patent reflects a deep understanding of the complexities involved in treating liver diseases, showcasing his expertise in pharmaceutical science.

Collaborations

Mooney has collaborated with esteemed colleagues, including Nigel R A Beeley and J Gordon Foulkes, to further enhance the development of his pharmaceutical innovations. These partnerships have contributed to the successful advancement of his research and the potential impact of his inventions in the medical field.

Conclusion

Kieran George Mooney's contributions to pharmaceutical treatments, particularly for non-alcoholic steatohepatitis, highlight his role as an innovator in the industry. His patent and collaborative efforts underscore the importance of research in developing effective medical solutions.